-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731. Clinical Autologous Transplantation: Results: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Biological, multiple myeloma, Diseases, Lymphoma (any), Non-Biological, Combinations, Therapies, chemotherapy, immune cells, T-Cell Lymphoma, Technology and Procedures, Cell Lineage, cytogenetics, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, pharmacology, transplantation
Monday, December 7, 2020: 7:00 AM-3:30 PM

Neeraj Saini, MD1, Junsheng Ma, MS2*, Melissa Timmons, PA-C3*, Amin M. Alousi, MD4, Paolo Anderlini3, Borje S. Andersson, M.D., Ph.D.3, Chitra Hosing, MD1, Jeremy Ramdial, MD1, Partow Kebriaei, MD3, Uday R. Popat, MD5, Muzaffar H. Qazilbash, MD3, Elizabeth J. Shpall, MD1, Samer A. Srour, MD, MS5, Benigno C. Valdez, PhD5, Bouthaina S. Dabaja, MD6*, Chelsea C. Pinnix, MD, PhD7*, Jillian R. Gunther, MD, PhD7*, Farzaneh Maadani, BS, MT5*, Gabriela Rondon1, Richard E. Champlin, MD1 and Yago Nieto, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
5Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Olivier Veilleux, MD1*, Francisco Socola, MD1, Sally Arai, MD, MS2, Robert Lowsky, MD, FRCP2, Judith A Shizuru, MD, PhD3, Parveen Shiraz, MD2, Lori Muffly, MD, MS4, Laura J. Johnston, MD5, Matthew J. Frank, MD, PhD2, Surbhi Sidana, MD1, Everett H Meyer, MD, PhD2*, Andrew R. Rezvani, MD2, David B. Miklos, MD, PhD2, Robert S. Negrin, MD5 and Wen-Kai Weng, MD, PhD2

1Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA
2Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
3Stanford Univ. Med. Ctr., Stanford, CA
4Assistant Professor of Medicine, Stanford University School of Medicine, Stanford, CA
5Stanford University School of Medicine, Stanford, CA

Kishore Kumar, MD, MBBS, DM and Chezhian Subash, FRCPath*

MIOT INSTITUTE OF HAEMATOLOGY, CHENNAI, India

Bicky Thapa, MD1*, Huaying Dong, MS2*, Sergey Tarima, PhD1* and Binod Dhakal, MS1

1Medical College of Wisconsin, Milwaukee, WI
2Medical College of Wisconsin, Milwaukee

Surbhi Sidana, MD1, Shaji K. Kumar, MD2, Raphael Fraser, PhD3*, Noel Estrada-Merly, MS4*, Maxim Norkin, MD, PhD5*, Sergio Giralt, MD6*, Muzaffar H. Qazilbash, MD7, Nina Shah, MD8 and Anita D'Souza, MD, MS9

1Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA
2Mayo Clinic Rochester, Division of Hematology, Rochester, MN
3Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
4CIBMTR (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin, Milwaukee, WI
5Baptist MD Anderson Cancer Center, Jacksonville, FL
6Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
9The Medical College of Wisconsin Inc., Milwaukee, WI

Qaiser Bashir, MD1, Peter F Thall, PhD2*, Dawen Sui2*, Cristina Knape3*, Jitesh Kawedia, BPharm4* and Muzaffar H. Qazilbash, MD5

1Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Laurent Garderet, MD, PhD1, Hafida Ouldjeriouat2*, Mohamed-Amine Bekadja3*, Elisabeth Daguenet, PhD4*, Laure Vincent5*, Damien roos Weil6*, Marguerite Vignon, MD7*, Mohamad Mohty, MD, PhD8, Julie Abraham, MD9*, Martine Escoffre-Barbe, MD10*, Bruno Lioure, MD11*, Redhouane Ahmed Nacer, MD, PhD12*, Denis Caillot13*, Clara Mariette, MD14*, Lionel Karlin, MD15*, Pierre Morel, MD16*, Lila Gilis, MD17*, Emanuelle Leray18*, Anaise Blouet, MD19*, Nicole Raus, Data Manager20*, Marie Robin, MD, PhD21, jean Jacques Boffa22*, Pierre Ronco23*, Marie Thérèse Rubio, MD, PhD24* and Jérôme Cornillon, MD25*

1Service Hematologie, Sorbonne Université, Hopital Pitié Salpêtière APHP, Paris, France
2hematology department, CHU Oran, Oran, Algeria
3Department of Hematology and Cell Therapy, EHU 1st Novembre 1954 Bir el Djir Usto, University Ahmed Benbella 1, Oran, Algeria
4Institut de Cancérologie Lucien Neuwirth, Saint Priest En Jarez, France
5CHU de Montpellier / Département d'hématologie clinique, Hôpital Saint-Eloi, Montpellier, France
6Hematology department, Sorbonne Université Hôpital Pitié Salpêtrière APHP, Paris, FRA
7Cochin Hospital, Hematology Department, Paris, France
8Saint Antoine Hospital, Paris, France
9Clinical Hematology Service, CHU Limoges, Limoges, FRA
10Hematology department, CHU Rennes, Rennes, France
11Département d'Hématologie et d'Oncologie, CHU Strasbourg, Strasbourg, FRA
12Department of Hematology and bone marrow transplant, CPMC, Algiers, Algeria
13CHU de Dijon, Service d'Hématologie, Dijon, France
14CHU Grenoble, Hematology, Grenoble, France
15Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Benite, France
16Department of Hematology, Chu Amiens, Salouel, France
17Centre Leon Berard, Departement d'Oncologie Medicale, Lyon, France
18Hematology department, CH Argenteuil, Argenteuil, France
19Service oncologie-hématologie, Centre Hospitalier, Cholet, Cholet, France
20SFGM-TC, Lyon, France
21Hôpital Saint-Louis, APHP, Paris, France
22Nephrology department, Sorbonne Université Hôpital Tenon APHP, Paris, France
23INSERM Umr_s 1155, Paris, FRA
24CHRU Nancy, Hôpital Brabois, Vandœuvre-les Nancy, France
25Hematology department, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez, France

Sarah Farag1*, Ulrike Bacher2*, Myriam Legros3*, Daniel Betticher4*, Jean-Marc Lüthi5*, Thomas Egger6*, Thilo Zander, MD7*, Barbara Jeker1* and Thomas Pabst, MD1

1Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
2Department of Hematology and Central Hematology Laboratory, University Hospital/Inselspital Bern, University of Bern, Switzerland, Bern, Switzerland
3Central Hematology Laboratory, University Hospital, Bern, Switzerland
4Department of Oncology, HFR Frioburg, Fribourg, Switzerland
5Department of Oncology, Regional Hospital Thun, Thun, Switzerland
6Department of Oncology, Cantonal Hospital Solothurn, Solothurn, Switzerland
7Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland

Chun-Kuang Tsai, MD1*, Chiu-Mei Yeh, MS1,2*, Ying-Chung Hong, MD3*, Po-Min Chen, MD. PhD.1*, Jin-Hwang Liu, MD. PhD.4,5*, Jyh-Pyng Gau, MD1* and Chia-Jen Liu, MD1,6

1Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
2Institute of Public Health, National Yang-Ming University, Taipei, Taiwan
3Division of Hematology and Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, TWN
4Division of Hematology and Oncology, Cheng Hsin General Hospital, Taipei, Taiwan, Taipei, Taiwan
5Chong Hin Loon Cancer and Biotherapy Research Center and Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan
6Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Samer A. Srour, MD, MS1, Yago Nieto, MD1, Swaminathan P Iyer, MD2, Roberto N. Miranda, MD3*, Farzaneh Maadani4*, Gabriela Rondon1, Neeraj Saini, MD1, Paolo Strati, MD5, May Daher6, Ranjit Nair, MD7, Bouthaina S. Dabaja, MD8*, Uday R. Popat, MD6, Muzaffar H. Qazilbash, MD1, Elizabeth J. Shpall, MD1, Christopher Flowers, MD, MS9, Richard E. Champlin, MD1, Chitra Hosing, MD1 and Issa F. Khouri, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
6Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma/Myeloma, University of Texas M.D. Anderson Cancer Center, Pearland, TX
8Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Abdullah S. Al Saleh, MBBS1, Iuliana Vaxman, MD, BA1*, Harsh Parmar, MD1, Alissa Visram, MD1, M Hasib Sidiqi, MBBS2, Eli Muchtar, MD1*, Francis K. Buadi, MB, CHB1*, David Dingli, MD, PhD1, Martha Q. Lacy, MD1, Rahma M Warsame, MD3, Wilson I Gonsalves, MD1, Taxiarchis Kourelis, MD1, William J Hogan, MB, BCh1, Prashant Kapoor, MD1, Robert Wolf, PharmD, RPh1*, Angela Dispenzieri, MD3, Shaji K. Kumar, MD1 and Morie Gertz1

1Mayo Clinic Rochester, Division of Hematology, Rochester, MN
2Mayo Clinic - Rochester, Perth, WEA, Australia
3Mayo Clinic, Rochester, MN

Fahmin Basher, MD, PhD1, Sandra Sanchez, MD2*, Jonathan H. Schatz, MD3, James E. Hoffman, MD4 and Lazaros J. Lekakis, MD5*

1Department of Medicine, University of Miami, Miller School of Medicine, Miami, FL
2Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL
3Department of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
4Department of Medicine, Division of Hematology, University of Miami Leonard M. Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL
5University of Miami, Sylvester Comprehensive Care Center, Miami, FL

Mariano Arribas1*, Gregory J Ahmann, BS1, Skye Buckner-Petty, MPH2*, Esteban Braggio, PhD1, Elitza S Theel, PhD3* and Rafael Fonseca, MD4

1Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
2Division of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
3Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ

*signifies non-member of ASH